rsv news - Search News

RSV, vaccine

Study confirms RSV vaccine's protective power for seniors

A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization.

RSV Vaccine Shows Strong Protection for Older Adults

A large new study says the RSV vaccine is 80% effective at preventing hospitalization in older adults due to complications from the illness, and works just as well at protecting them from death or needing intensive care unit support for severe complications.

cidrap.umn · 8h

RSV vaccine effective in preventing hospitalizations in older Americans

Today, The Lancet published the first real-world data analysis of respiratory syncytial virus (RSV) vaccine efficacy among older US adults in a large multistate study. The study shows the vaccine was 80% effective in protecting against hospitalizations and deaths during the 2023-2024 RSV season.

11hon MSN

Shawn Johnson Details Son's 'Scary' Experience with RSV That Led to Hospitalization: 'He Couldn't Breathe' (Exclusive)

Shawn Johnson shares daughter Drew Hazel, 4, and sons Jett James, 2, and Barrett 'Bear' Madison, 10 months, with her husband ...

19hon MSN

Merck's RSV antibody for infants effective in reducing some types of infections in study (Oct 17)

(Corrects headline, paragraph 1 and 2 in Oct. 17 story to show the drug reduced medically attended lower respiratory ...

31m

CT officials urge flu, COVID, RSV vaccination as flu season starts

Two people have died of influenza so far this season, CT health officials said while urging residents to stay up-to-date on ...

Potential competition for RSV prophylactic Beyfortus

New data released by Merck suggests AstraZeneca and Sanofi’s Beyfortus, the monoclonal antibody injection that protects ...

ConsumerAffairs3d

RSV gets no respect although it is a common virus and can be severe

RSV is a virus that can make people sick, especially older adults and babies. But even though RSV can be serious, people aren ...

ENDPOINTS NEWS19h

Merck unveils RSV antibody data, in bid to compete with AstraZeneca and Sanofi

Merck’s experimental antibody for RSV reduced infants’ risk of certain lower respiratory infections by 60.4% compared to ...

New RSV vaccine guidelines: Adults 75+ urged to vaccinate

AUSTIN (KXAN) — In 2023, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) ...

LancasterOnline11h

Ephrata hospital now offers RSV immunizations to newborns

WellSpan Ephrata Community Hospital is now offering respiratory syncytial virus immunizations to infants born at the hospital ...

20h

Merck's RSV antibody for infants effective in reducing some types of infections in study

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

pharmaphorum16h

MSD preparing to take on Beyfortus with RSV antibody

In the study, clesrovimab (MK-1654) significantly reduced the incidence of RSV disease and hospitalisations in healthy ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results